The Journal of Targeted Oncology Research is dedicated to advancing research and innovation in cancer biology, precision oncology, and targeted cancer therapeutics. The journal provides a platform for researchers, oncologists, clinicians, and healthcare professionals to share original research, clinical studies, reviews, and emerging perspectives that improve the understanding, diagnosis, prevention, and treatment of cancer.

The journal welcomes basic, translational, and clinical research focused on molecularly driven approaches to cancer management. By publishing high-quality peer-reviewed content, the journal aims to bridge discoveries in cancer biology with clinical applications, promote personalized treatment strategies, and foster global collaboration in oncology research.

Key Areas of Interest

Clinical Oncology – Diagnosis, staging, management, and treatment of malignant diseases.
Precision & Personalized Oncology – Tailored cancer care guided by patient-specific molecular profiles, genetic information, clinical features, and therapeutic response.
Targeted Cancer Therapies – Molecularly targeted drugs, pathway inhibitors, monoclonal antibodies, and emerging targeted approaches.
Cancer Molecular Biology – Molecular mechanisms of tumor development, progression, invasion, and metastasis.
Cancer Genetics & Molecular Profiling – Research examining genetic patterns in tumors, inherited cancer risk, alterations in cellular DNA, and their relevance to tumor characteristics and clinical outcomes.
Immuno-Oncology – Cancer immunotherapy, immune checkpoint inhibitors, cellular therapies, cancer vaccines, and tumor–immune interactions.
Drug Discovery & Development – Novel anticancer agents, therapeutic targets, preclinical development, and translational drug research.
Biomarkers & Molecular Diagnostics – Identification and application of molecular indicators for early cancer detection, disease characterization, prognosis, and selection of appropriate therapies.
Resistance & Treatment Response – Study of factors influencing therapeutic effectiveness, acquired and intrinsic resistance, tumor diversity, and approaches for improving responses to anticancer treatment.
Radiation & Surgical Oncology – Advances in radiation therapy, surgical oncology, image-guided interventions, and integrated cancer treatment.
Tumor Microenvironment & Cancer Metabolism – Tumor–host interactions, cancer metabolism, angiogenesis, inflammation, and microenvironmental regulation.
Nanomedicine & Therapeutic Delivery – Research into nano-enabled approaches for improving the localization, controlled release, and performance of anticancer treatments.
Hematologic Malignancies – Leukemias, lymphomas, multiple myeloma, and targeted therapeutic approaches in blood cancers.
Translational & Experimental Oncology – Preclinical models, molecular mechanisms, regenerative approaches, and laboratory-to-clinic research.
Cancer Epidemiology & Global Oncology – Cancer burden, prevention, disparities, population-based research, and global approaches to cancer care.